Cabaletta Bio (NASDAQ:CABA) executives told investors at the Guggenheim Emerging Outlook Biotech Summit 2026 that the company has initiated enrollment in what it described as its first pivotal program ...

Immune cells in the brain that go rogue contribute to the death of neurons, so getting rid of them may slow the progression of neurodegenerative conditions like amyotrophic lateral sclerosis ...

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack. A newly published study reports that a molecule involved in controlling gen ...

Nemolizumab monotherapy is effective and well-tolerated among adults with moderate to severe prurigo nodularis through 100 weeks.

Many public-health authorities recommend the shingles vaccine for people between 65 and 80 (although the range varies by region). The sharp age cut-offs used in the roll-out in each country or region, ...

Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that ...